DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS?
- 25 October 1980
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 316 (8200), 915-916
- https://doi.org/10.1016/s0140-6736(80)92072-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administrationLife Sciences, 1980
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979
- INCREASED DOPAMINE CONCENTRATION IN LIMBIC AREAS OF BRAIN FROM PATIENTS DYING WITH SCHIZOPHRENIABrain, 1979
- Anti-platelet action of intravenous infusion of prostacyclin in manThrombosis Research, 1978
- Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brainsNature, 1978
- Use of ADTN to define specific 3H-spiperone binding to receptors in brainNature, 1978
- 3H-spiroperidol labels dopamine receptors in pituitary and brainEuropean Journal of Pharmacology, 1977
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Inhibition of stress ulcer formation with somatostatin in ratsZeitschrift für Die Gesamte Experimentelle Medizin, 1976
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974